Christoph J Griessenauer, Alejandro Enriquez-Marulanda, Philipp Taussky, Arundhati Biswas, Ramesh Grandhi, Sissi Xiang, Tao Hong, Lorenzo Rinaldo, Giuseppe Lanzino, Waleed Brinjikji, Jan-Karl Burkhardt, Peter Kan, Mandeep Ghuman, Victor X D Yang, Karen Chen, Mohammad A Aziz-Sultan, Mohammad Ghorbani, Clemens M Schirmer, Oded Goren, Shamsher S Dalal, Monika Killer-Oberpfalzer, Erasmia Müller-Thies-Broussalis, Matthew J Koch, Christopher J Stapleton, Aman B Patel, Paul M Foreman, Marshall C Cress, Robert A Hirschl, Timo Krings, Hongqi Zhang, Adam A Dmytriw
BACKGROUND: The Pipeline Embolization Device (PED; Medtronic) has been used off-label for the treatment of challenging posterior circulation aneurysms. Data on this modality are primarily limited to small retrospective single-center series. OBJECTIVE: To assess safety and efficacy of this treatment by establishing an international, multicenter collaboration. METHODS: Consecutive posterior circulation aneurysms treated with the PED from 2012 to 2019 across 11 neurovascular centers were retrospectively reviewed...
November 16, 2020: Neurosurgery